Erik Roy Hillesland v. Glenmark Pharmaceuticals, Inc. USA

Opinion

[DO NOT PUBLISH]

In the

United States Court of Appeals For the Eleventh Circuit

____________________

No. 23-11047

Non-Argument Calendar

____________________

IN RE: ZANTAC (RANITIDINE) PRODUCTS LIABILITY LITIGATION. 9:20-md-02924-RLR

___________________________________________________

ERIK ROY HILLESLAND, CHANMEIKA HILL, Interested Parties-Appellants, versus GLENMARK PHARMACEUTICALS, INC. USA, MARLENE GOLDENBERG, APOTEX CORP., MICHAEL MCCANDLESS,

2

2 Opinion of the Court 23-11047

BRAD ALDRIDGE, et al.,

Defendants-Appellees.

____________________

Appeal from the United States District Court for the Southern District of Florida D.C. Docket No. 9:20-md-02924-RLR

____________________

Before WILSON, JILL PRYOR, and GRANT, Circuit Judges. PER CURIAM:

Upon review of the record and the response to the jurisdictional questions, this appeal is DISMISSED for lack of jurisdiction. Appellant lacks standing to bring this appeal because there is no evidence that he is, or ever was, a plaintiff in this action, and there is no indication that the district court has ever entered an appealable order that caused him injury. See Wolff v. Cash 4 Titles, 351 F.3d 1348, 1353-54 (11th Cir. 2003); Mickles on behalf of herself v. Country Club, Inc., 887 F.3d 1270, 1278 (11th Cir. 2018).